Interrelationship of Plasma Free Fatty Acids and Blood Beta-Hydroxybutyrate Concentration in Coronary Artery Disease

1974 ◽  
pp. 529-531
Author(s):  
P. Gosh ◽  
C. N. Hales
2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Giovanni Tarantino ◽  
Carmine Finelli ◽  
Franco Scopacasa ◽  
Fabrizio Pasanisi ◽  
Franco Contaldo ◽  
...  

The present study shows low circulating levels of SIRT4 in obese patients with nonalcoholic fatty liver disease mirroring its reduced mitochondrial expression in an attempt to increase the fat oxidative capacity and then the mitochondrial function in liver and in muscle. SIRT4 modulates the metabolism of free fatty acids reducing their high circulating levels but, unfortunately, increasing ROS production. Great concentration of free fatty acids, released by adipose tissue, coupled with oxidative stress, directly results in endothelial dysfunction, early atherosclerosis, and coronary artery disease risk factor.


2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Jing-Lu Jin ◽  
Ye-Xuan Cao ◽  
Hui-Hui Liu ◽  
Hui-Wen Zhang ◽  
Yuan-Lin Guo ◽  
...  

Abstract Background The aim of the present study is to examine the effects of free fatty acids (FFAs) on major cardiovascular events (MACEs) in patients with stable coronary artery disease (CAD) and different glucose metabolism status. Methods In this study, we consecutively enrolled 5443 patients from March 2011 to May 2015. Patients were categorized according to both status of glucose metabolism status [diabetes mellitus (DM), pre-diabetes (Pre-DM), normal glycaemia regulation (NGR)] and FFAs levels. All subjects were followed up for the occurrence of the MACEs. Results During a median of 6.7 years’ follow-up, 608 MACEs occurred. A twofold higher FFAs level was independently associated with MACEs after adjusting for confounding factors [Hazard Ratio (HR): 1.242, 95% confidence interval (CI) 1.084–1.424, p value = 0.002]. Adding FFAs to the Cox model increased the C-statistic by 0.015 (0.005–0.027). No significant difference in MACEs was observed between NGR and Pre-DM groups (p > 0.05). When patients were categorized by both status of glucose metabolism and FFAs levels, medium and high FFAs were associated with significantly higher risk of MACEs in Pre-DM [1.736 (1.018–2.959) and 1.779 (1.012–3.126), all p-value < 0.05] and DM [2.017 (1.164–3.494) and 2.795 (1.619–4.824), all p-value < 0.05]. Conclusions The present data indicated that baseline FFAs levels were associated with the prognosis in DM and Pre-DM patients with CAD, suggesting that FFAs may be a valuable predictor in patients with impaired glucose metabolism.


2014 ◽  
Vol 13 (1) ◽  
pp. 111 ◽  
Author(s):  
Olga Gruzdeva ◽  
Evgenya Uchasova ◽  
Yulia Dyleva ◽  
Ekaterina Belik ◽  
Victoria Karetnikova ◽  
...  

2006 ◽  
Vol 91 (7) ◽  
pp. 2542-2547 ◽  
Author(s):  
Stefan Pilz ◽  
Hubert Scharnagl ◽  
Beate Tiran ◽  
Ursula Seelhorst ◽  
Britta Wellnitz ◽  
...  

Abstract Context: Free fatty acids (FFAs) are associated with several cardiovascular risk factors and exert harmful effects on the myocardium. Objective: The aim of our study was to elucidate the relationship between FFAs and mortality in subjects who underwent coronary angiography. Design, Setting, and Participants: Ludwigshafen Risk and Cardiovascular Health is a prospective cohort study of Caucasians who had undergone coronary angiography at baseline (1997–2000). During a median time of follow-up of 5.38 yr, 513 deaths had occurred among 3315 study participants with measured FFAs. Main Outcome Measure: Hazard ratios for mortality according to FFA levels were measured. Results: At the fourth quartile of FFAs, fully adjusted hazard ratios for death from any cause and cardiovascular causes were 1.58 (P = 0.002) and 1.83 (P = 0.001), respectively. In persons with angiographic coronary artery disease (CAD), stable CAD, and unstable CAD, the predictive value of FFAs was similar to that in the entire cohort, but the association did not attain statistical significance in persons without CAD analyzed separately. FFA levels were not related to the presence of angiographic CAD but were elevated in subjects with unstable CAD, compared with probands with stable CAD. Furthermore, FFAs increased with the severity of heart failure and were positively correlated with N-terminal pro-B-type natriuretic peptide (P &lt; 0.001). Conclusions: FFA levels independently predict all-cause and cardiovascular mortality in subjects with angiographic CAD. A possible diagnostic use of FFAs warrants further studies, but our results may underline the importance of therapeutic approaches to influence FFA metabolism.


Sign in / Sign up

Export Citation Format

Share Document